Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs […]
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles Read More »
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds Read More »
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
Britain to Study Use of Lilly’s Weight Loss Drug to Get People Back to Work Read More »
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
Compounding Group Sues FDA Over Removal of Lilly’s Weight Loss Drug from Shortage List Read More »
Eli Lilly (NYSE: LLY) is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely
Eli Lilly (NYSE: LLY) Invests $1.8 Billion to Expand Production of Key Drugs in Ireland Read More »
On Tuesday, Eli Lilly (NYSE: LLY) said it has begun selling vials of the lowest starter dose of its popular
Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service
NHS Likely to Block Eli Lilly (NYSE: LLY) Alzheimer’s Treatment, The Telegraph Reports Read More »
NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite
Doctors Face Hurdles in Securing Wegovy for Older Americans with Heart Disease Read More »
Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY)
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report Read More »
Copyright © 2024 abbonews.com
